-
December SPAC Merger Calendar: Upcoming Votes, Stocks To Watch
05 Dec 2021 23:44 GMT
… have a low float for shares available.
December SPAC Merger Calendar … Merger Calendar: Upcoming Votes, Earnings, Stocks To Watch
Dec. 15: Investindustrial … Biosciences: Biopharmaceutical company Pardes counts Gilead Sciences (NASDAQ: GILD) as an investor …
-
Why Are Arcus Biosciences Shares Trading Higher Today?
18 Nov 2021 15:10 GMT
Gilead Sciences Inc (NASDAQ: GILD) has exercised … to $100.
Price Action: RCUS shares are up 15.4% at …
-
Arcus Biosciences shares rocket premarket after Gilead exercises options for 3 cancer programs for $725 million
18 Nov 2021 12:52 GMT
Shares of Arcus Biosciences Inc.
RCUS,
- … in premarket trading Thursday, after Gilead Sciences Inc.
GILD,
+0.85%
said … said in a statement. Arcus shares have gained 42% in the …
-
Global CART Cell Therapy Market Analysis, Company Profile, Future Estimations by 2027
04 Dec 2021 19:20 GMT
… are profiled with their market shares in the worldwide Market Scenario … Biopharma Inc, Kite Pharma Inc. (Gilead Sciences Inc.), Novartis International AG, Legend …
-
Former pharma exec, publicist charged with insider trading
02 Dec 2021 22:15 GMT
… the company's stock shares, according to a federal criminal … of the company’s stock shares, according to a federal … She also sold her options shares for $144,000 and gave … were left seeking comment from Gilead Sciences.
Copyright
© 2021 The Associated …
-
FDA advisers recommend Merck’s COVID-19 pill in close vote
30 Nov 2021 22:43 GMT
… the drug in pregnant women. Shares of Merck
MRK,
+0.03% … includes the steroid dexamethasone and Gilead Sciences Inc.’s
GILD,
-2.43% …
-
FDA advisers recommend Merck’s COVID-19 pill in close vote
30 Nov 2021 16:08 GMT
… the drug in pregnant women. Shares of Merck
MRK,
+0.03% … includes the steroid dexamethasone and Gilead Sciences Inc.’s
GILD,
-2.43% …
-
Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial
24 Nov 2021 15:09 GMT
Gilead Sciences Inc (NASDAQ: GILD) and Merck … clinical trials.
Price Action: MRK shares are down 0.07% at …
-
CAR T-Cell Therapy Is The Key Trend In The Cell And Gene Therapy Market
22 Nov 2021 12:59 GMT
… are Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals, Inc., Alnylam Pharmaceuticals … competitors’ revenues, profiles, and market shares.
Request For A Sample Of …
-
Government Initiatives Have A Significant Impact On The HIV Drugs Market
22 Nov 2021 12:59 GMT
… global HIV drugs market are Gilead Sciences, Inc, GlaxoSmithKline plc., Johnson … , profiles, and HIV drugs market shares.
Request For A Sample Of …
About
© 1995-2021